跳至主要内容
临床试验/JPRN-UMIN000015386
JPRN-UMIN000015386已完成未知

Feasibility of Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving 5-day chemotherapy rejimens - Feasibility of Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving 5-day chemotherapy rejimens

ational cancer center hospital0 个研究点目标入组 18 人开始时间: 2014年10月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • a)patients who had diabetes mellitus or past history of diabetes mellitus b)patients who take adrenaline beginning chemotherapy. c)patients who take barbituric acid beginning chemotherapy. d)patients who had received any chemotherapy. e)patients who take opioid. f)patients who have nausea or vomiting starting study. g)Active infectious diseases h)Severe complications i)history of hypersensitivity or allergy for study drugs or similar compounds. j)patients with clinically problematic, psycho-neurologic diseases k)pregnant, breastfeeding or expecting woman. l) patients with symptomatic brain metastasis m)patients with obstruction of gastrointestinal tract, for example ileus etc. n)patients who are disqualified by attending physicians o)patients with gastrointestinal cancer

研究者

相似试验